Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy Bodies

202197 citationsJournal Articlebronze Open Access

Authors

Maria Camila González · University of Stavanger

Nicholas J. Ashton · University of Gothenburg

Bárbara Fernandes Gomes · University of Gothenburg

Diego Tovar · Stavanger University Hospital

‪Frederic Blanc‬ · Université de Strasbourg

Thomas K. Karikari · University of Gothenburg

Brit Mollenhauer

Abstract

This study suggests that plasma p-tau181 and p-tau231 levels may be used as cost-effective and accessible biomarkers to assess cognitive decline in individuals with DLB.

Topics & Keywords

Dementia and Cognitive Impairment Research Alzheimer's disease research and treatments Neurological Disease Mechanisms and Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA Neurology

Volume 79, Issue 1, pp. 32-32

DOI: 10.1001/jamaneurol.2021.4222

Field-Weighted Citation Impact: 9.16